MSLN and pancreatic ductal adenocarcinoma: Our previous studies demonstrated that mesothelin (MSLN) plays a significant role in pancreatic ductal adenocarcinoma (PDAC) by promoting cell proliferation, migration, and invasion while inhibiting apoptosis [12,13,16,17].